InMode (INMD) FCF Payout Ratio Growth (5y) (2023 - 2026)
InMode (INMD) FCF Payout Ratio Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | InMode | 913.43 Mn | 498.26 Mn | 71.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.64% |
| Sep 30, 2025 | 35.19% |
| Jun 30, 2025 | -26.60% |
| Mar 31, 2025 | 7.31% |
| Sep 30, 2024 | 6.12% |
| Jun 30, 2024 | 6.96% |
| Mar 31, 2024 | -3.67% |
| Dec 31, 2023 | -1.83% |
| Sep 30, 2023 | 2.64% |
| Jun 30, 2023 | 3.38% |